Site Members can sign up for company wide alerts
Lawsuit Overview
August 31, 2022 - An investor in shares of Abbott Laboratories (NYSE: ABT) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by Abbott Laboratories in connection with certain allegedly false and misleading statements made between February 19, 2021 and June 8, 2022. Chicago, IL based Abbott Laboratories, ...
You must register (for free) or login to view the entire case.